APA

Bertaut A., Truntzer C., Madkouri R., Kaderbhai C. G., Derangère V., Vincent J., Chauffert B., Aubriot-Lorton M. H., Farah W., Mourier K. L., Boidot R. & Ghiringhelli F. (20180223). Blood baseline neutrophil count predicts bevacizumab efficacy in glioblastoma. : Oncotarget.

Chicago

Bertaut Aurélie, Truntzer Caroline, Madkouri Rachid, Kaderbhai Coureche Guillaume, Derangère Valentin, Vincent Julie, Chauffert Bruno, Aubriot-Lorton Marie Hélene, Farah Wahlid, Mourier Klaus Luc, Boidot Romain and Ghiringhelli Francois. 20180223. Blood baseline neutrophil count predicts bevacizumab efficacy in glioblastoma. : Oncotarget.

Harvard

Bertaut A., Truntzer C., Madkouri R., Kaderbhai C. G., Derangère V., Vincent J., Chauffert B., Aubriot-Lorton M. H., Farah W., Mourier K. L., Boidot R. and Ghiringhelli F. (20180223). Blood baseline neutrophil count predicts bevacizumab efficacy in glioblastoma. : Oncotarget.

MLA

Bertaut Aurélie, Truntzer Caroline, Madkouri Rachid, Kaderbhai Coureche Guillaume, Derangère Valentin, Vincent Julie, Chauffert Bruno, Aubriot-Lorton Marie Hélene, Farah Wahlid, Mourier Klaus Luc, Boidot Romain and Ghiringhelli Francois. Blood baseline neutrophil count predicts bevacizumab efficacy in glioblastoma. : Oncotarget. 20180223.